Home » Topics » Disease categories and therapies » Immune

Immune
RSS

Monoclonal antibodies targeting CD40 claimed by Kirin Brewery

Dec. 30, 2002

Novartis files NDA for Certican for prevention of kidney and heart transplant rejection

Dec. 30, 2002

TBC-MVA smallpox vaccine enters phase I testing

Dec. 30, 2002

VaxGen and Kaketsuken sign agreement for smallpox vaccine development

Dec. 27, 2002

Alliance and Mixture Sciences enter technology license agreement

Dec. 27, 2002

Shigella vaccine is safe and immunogenic in phase I trial

Dec. 27, 2002

Incell develops oral smallpox vaccine

Dec. 23, 2002

Coley receives funding to develop CpG oligos for enhancement of vaccines

Dec. 20, 2002

VRBPAC recommends the FDA approve intranasal influenza vaccine

Dec. 18, 2002

Approval granted by FDA for GlaxoSmithKline's Pediarix combination vaccine

Dec. 18, 2002

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 27, 2026.
Detecting the invisible: minimal residual disease at AACR 2026
BioWorld Science
Minimal residual disease (MRD) has become a central concept in modern oncology, reshaping how clinicians evaluate response, relapse risk and treatment precision....
A free gene therapy? Regeneron’s Otarmeni approved for hearing loss
BioWorld
Children and adults with a type of congenital hearing loss now have a free treatment option, with the U.S. FDA’s accelerated approval of Regeneron Pharmaceuticals...
AACR 2026: The age of agentic AI in oncology
BioWorld Science
New Approach Methodologies (NAMs) for drug development are transforming biomedical research by replacing or complementing animal models. More than 90% of...
Chengdu Mfs Pharma synthesizes new compounds for pain
BioWorld Science
Chengdu Mfs Pharma Co. Ltd. has prepared and tested compounds for the potential treatment of pain, sleep disorder and status epilepticus epilepsy as well as for...